Skip to main content

Innovation Theaters

Tuesday, October 19

Stand Strong Against Platelet Destruction With TAVALISSE: A Patient's ITP Treatment Journey
Time: 12:10 PM
Speaker: Yousuf Gaffar, MD
Presented by: 

" "

Wednesday, October 20

AML Patient Cases and Supporting Data
Time: 10:15 AM
Speaker: Jonathan Abbas, MD 
Presented by:
BMS

A Case-based Discussion on Improving Outcomes in Patients With Newly- Diagnosed Secondary AML
Time: 10:15 AM
Speaker: Catherine Lai, MD, MPH
Presented by:
Jazz

ICLUSIG®(ponatinib): Taking Action At The Critical Moment

Time: 1:10 PM
Speaker: James McCloskey, MD
Presented by:

Takeda

Pivotal Phase 3 Data In Newly Diagnosed AML

Time: 1:10 PM
Speaker: Michael Schuster, MD
Presented by:

Genentech

Thursday, October 21

A Combination Therapy for previously treated Follicular Lymphoma
Time: 9:30 AM
Speaker: Nilanjan Ghosh, MD, PhD
Presented by:
BMS

NINLARO® (ixazomib): Durable Strength When Navigating the Difficulties of Multiple Myeloma in the Real World
Time: 9:30 AM
Speaker: Ehsan Malek, MD
Presented by:
Takeda

Discover the Role of Two Immunotherapies in Myeloma Treatment
Time: 12:45 PM
Speaker: Perry Cook, MD
Presented by:
BMS

Blenrep For Injection 100mg
Time: 12:45 PM
Speakers: Robert Vescio, M.D. ; Shaily Dinesh Shah, M.D.
Presented by: 
GSK

 

New York Lymphoma Rounds
Time: 7:00 PM
Speaker: Gilles Salles, MD, PhD ; Richard R. Furman, MD ; Francine Foss, MD

Presented by:
LRF Logo

Friday, October 22

Use of a Targeted Agent For Previously Untreated or R/R CLL
Time: 10:50 AM
Speaker: Javier Pinilla-Ibarz, MD, PhD
Presented by:
AZ

Evolving Treatment Approaches in MDS & CMML
Time: 1:15 PM
Speaker: Ralph Boccia, MD
Presented by:
Taiho

 

Exploring a First-in-Class Therapy for CLL and Newly Diagnosed AML: Pivotal Phase 3 Data that Support Treatment Decisions and Patient Care
Time: 1:15 PM
Speaker: Ryan Jacobs, MD
Presented by: 

" "

 

Saturday, October 23

Study Results from the First and Only Pivotal Randomized Trial in R/R DLBCL
Time: 10:00 AM
Speaker: Charles Farber
Presented by:
Genentech

cHL LCU Lymphoma Clinical Update
Time: 12:45 PM
Speaker: Hillard M. Lazarus, MD
Presented by: Seagen

" "

A Treatment Option for Relapsed/Refractory Marginal Zone and Follicular Lymphomas
Time: 12:45 PM
Speaker: Dr. Owen O’Connor, M.D., Ph.D
Presented by: TG Therapeutics

" "


 

These non-CME presentations are taking place during the Lymphoma Leukemia & Myeloma Congress. The opinions and recommendations expressed do not necessarily reflect the views of the Lymphoma Leukemia & Myeloma Congress, Imedex, HMP Global or NACCME. These programs are not intended or eligible for continuing education (CME/CE) credits and do not meet guidelines governing CME/CE. By participating or entering these presentations, you opt-in to share and receive information from industry sponsors. If you wish to opt-out, please speak with a conference representative or email llm-optout@hmpglobal.com.